NUCL:SW:SW-VanEck Uranium and Nuclear Technologies UCITS ETF A USD Acc CHF (CHF)

ETF | Others |

Last Closing

USD 28.625

Change

+0.21 (+0.72)%

Market Cap

USD 0.43B

Volume

1.43K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-21 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
CHDIV:SW UBS ETF (CH) - MSCI Switzerlan..

-0.02 (-0.14%)

USD 1,244,681.59B
SPISI:SW UBS ETF (CH) - SPI® ESG (CHF)..

-0.05 (-0.27%)

USD 590,186.66B
SWICHA:SW UBS ETF (CH) – MSCI Switzerl..

-0.03 (-0.14%)

USD 226,274.25B
SWUSAH:SW UBS ETF (CH) – MSCI Switzerl..

+0.04 (+0.12%)

USD 226,274.21B
SWEUAH:SW UBS ETF (CH) – MSCI Switzerl..

N/A

USD 226,274.20B
RGLDS:SW Raiffeisen ETF Solid Gold A US..

N/A

USD 134,034.93B
RGLDSH:SW Raiffeisen ETF Solid Gold H CH..

+165.00 (+2.62%)

USD 134,034.91B
RGLDOH:SW Raiffeisen ETF Solid Gold Ounc..

+13.50 (+0.67%)

USD 134,034.86B
RGLDO:SW Raiffeisen ETF Solid Gold Ounc..

+3.00 (+0.12%)

USD 134,034.85B
SPICHA:SW UBS ETF (CH) – SPI® (CHF) A..

-0.21 (-0.26%)

USD 131,872.43B

ETFs Containing NUCL:SW

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.28% 27% F 29% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.28% 26% F 28% F
Trailing 12 Months  
Capital Gain 4.28% 54% F 55% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.28% 50% F 51% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 12.17% 84% B 84% B
Dividend Return 12.17% 84% B 83% B
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 19.48% 9% A- 18% F
Risk Adjusted Return 62.47% 43% F 49% F
Market Capitalization 0.43B 52% F 47% F

Annual Financials (CHF)

Quarterly Financials (CHF)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.